The XenCart Protocol: A Method for Alcian Blue Labeling and Quantitative Analysis of Craniofacial Cartilage in Xenopus

Craniofacial birth defects, such as cleft lip and palate, are among the most common congenital anomalies and often arise from disruptions in early facial patterning. Many of these defects are linked to environmental teratogens, yet such exposures cannot be directly tested in humans, making animal models essential for evaluating developmental risks. Xenopus laevis offers a powerful solution: its tadpoles develop externally, share deeply conserved craniofacial patterning mechanisms with humans, and provide an accessible platform for uncovering how environmental exposures reshape facial structures during development. Here, we present the XenCart Protocol, a reproducible workflow for Alcian Blue staining and quantitative morphometric analysis of Xenopus craniofacial cartilage. This method provides clear visualization of individual cartilage elements and can be readily applied to investigate genetic or environmental perturbations. The Xenopus craniofacial skeleton contains distinct cartilaginous structures that perform key biomechanical functions and share strong homology with regions of the human craniofacial skeleton. These similarities allow direct comparison of developmental outcomes across vertebrates. As part of a CURE-based undergraduate course, the XenCart Protocol was used to measure jaw cartilage dimensions in tadpoles exposed to an emerging teratogen, e-liquids used in vaping. E-liquid exposure caused consistent reductions across major craniofacial cartilages, including shorter Meckel's cartilage, narrowed infrarostral width, decreased basihyobranchial and ceratohyal dimensions, and reduced suprarostral angles, reflecting an overall shift toward a smaller, more compact craniofacial morphology. These patterns suggest potential disruption of neural crest cell migration or signaling pathways for craniofacial cartilage development, mechanisms that, if similarly affected in humans, could contribute to midfacial narrowing, jaw underdevelopment, or increased vulnerability to conditions such as orofacial clefts. The ability to detect robust, structure-specific differences highlights the sensitivity of the protocol and its strong alignment with student-led research. These findings also pinpoint the precise regions of the jaw most affected by e-liquid exposure, providing a foundation for uncovering the developmental mechanisms driving these craniofacial changes. In summary, the XenCart Protocol provides a standardized, scalable method for quantifying craniofacial cartilage development and offers a powerful platform for both mechanistic research and undergraduate training in developmental biology and toxicology.